Loading clinical trials...

OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection | Clinical Trials | Clareo Health

COMPLETEDNCT06343350

OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection

In the United States, only 62% of the 37 million people with diabetes receive annual screening exams for diabetic retinopathy. One of the goals of the US Department of Health and Human Services Health...

Lead sponsor: Optain Health•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783 · Metabolic Disorders, Cancer, and more

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGEARLY Phase 1

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

NCT07395050 · Stage 3 Type 1 Diabetes

RECRUITINGNA

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT01399385 · Healthy, Obesity, and more

RECRUITING

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 27, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment300

Start dateApr 2024

Last updatedFeb 27, 2026

Condition

Diabetic Retinopathy Diabetes

Locations shown

Gastro SB

Chula Vista, California

Triwest Research Associates

San Diego, California

Gulf Coast Clinical Research

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 27, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions